We are live on ! Find out more
IHM

Iguana Healthcare Management Portfolio holdings

AUM $152M
1-Year Est. Return 48.74%
This Fund
S&P 500
This Quarter Est. Return
-13.79%
1 Year Est. Return
+48.74%
3 Year Est. Return
+142.13%
5 Year Est. Return
10 Year Est. Return
AUM
$273M
AUM Growth
-$31M
Cap. Flow
+$3.24M
Cap. Flow %
1.19%
Top 10 Hldgs %
41.92%
Holding
103
New
39
Increased
16
Reduced
16
Closed
28

Top Buys

Rank Stock Value
1
ZBH icon
Zimmer Biomet
ZBH
+$8.47M
2
MDVN
MEDIVATION, INC.
MDVN
+$7.8M
3
MDT icon
Medtronic
MDT
+$7.53M
4
HCA icon
HCA Healthcare
HCA
+$6.98M
5
PFE icon
Pfizer
PFE
+$6.02M

Sector Composition

Rank Sector Weight
1 Healthcare 67.79%
2 Industrials 0.39%
3 Consumer Staples 0%
4 Financials 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CELG
1
DELISTED
Celgene Corp
CELG
$17.5M 6.42%
175,000
-25,000
-13% -$2.57M
CI icon
2
Cigna
CI
$71.7B
$13.7M 5.03%
100,000
-35,000
-26% -$4.81M
XNTK icon
3
PUT
State Street SPDR NYSE Technology ETF
XNTK
$2.2B
$12.9M 4.73%
+250,000
New +$12.3M
MDVN
4
DELISTED
MEDIVATION, INC.
MDVN
$12.2M 4.46%
265,000
+215,000
+430% +$7.8M
BAX icon
5
Baxter International
BAX
$14.4B
$11.9M 4.37%
290,000
-35,000
-11% -$1.33M
OEF icon
6
PUT
iShares S&P 100 ETF
OEF
$20.4B
$11.1M 4.05%
+100,000
New +$8.72M
SPY icon
7
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$819B
$10.3M 3.77%
+50,000
New +$9.76M
ZBH icon
8
Zimmer Biomet
ZBH
$18.8B
$9.06M 3.32%
+87,550
New +$8.47M
MRK icon
9
Merck
MRK
$318B
$7.94M 2.91%
157,200
+52,400
+50% +$2.57M
BIIB icon
10
Biogen
BIIB
$30.1B
$7.81M 2.86%
30,000
+10,000
+50% +$2.64M
GILD icon
11
Gilead Sciences
GILD
$161B
$7.81M 2.86%
85,000
-5,000
-6% -$451K
HCA icon
12
HCA Healthcare
HCA
$88.2B
$7.8M 2.86%
+100,000
New +$6.98M
RARE icon
13
Ultragenyx Pharmaceutical
RARE
$2.49B
$7.6M 2.78%
120,000
+5,000
+4% +$327K
MDT icon
14
Medtronic
MDT
$110B
$7.5M 2.75%
+100,000
New +$7.53M
PFE icon
15
Pfizer
PFE
$148B
$5.93M 2.17%
+210,800
New +$6.02M
LLY icon
16
Eli Lilly
LLY
$1.05T
$5.4M 1.98%
+75,000
New +$5.67M
AMGN icon
17
Amgen
AMGN
$218B
$5.25M 1.92%
35,000
-65,000
-65% -$9.66M
BIIB icon
18
CALL
Biogen
BIIB
$30.1B
$5.21M 1.91%
+20,000
New +$5.28M
THC icon
19
Tenet Healthcare
THC
$20.9B
$5.06M 1.86%
175,000
+100,000
+133% +$2.6M
NUVA
20
DELISTED
NuVasive, Inc.
NUVA
$4.87M 1.78%
100,000
+50,000
+100% +$2.27M
OMED
21
DELISTED
OncoMed Pharmaceuticals, Inc.
OMED
$4.72M 1.73%
467,025
+67,025
+17% +$787K
SUPN icon
22
Supernus Pharmaceuticals
SUPN
$2.76B
$4.19M 1.54%
275,000
+125,000
+83% +$1.63M
GBT
23
DELISTED
Global Blood Therapeutics, Inc.
GBT
$3.96M 1.45%
250,000
+140,000
+127% +$2.49M
ALNY icon
24
Alnylam Pharmaceuticals
ALNY
$30.3B
$3.77M 1.38%
60,000
+35,000
+140% +$2.33M
BSX icon
25
Boston Scientific
BSX
$72.5B
$3.76M 1.38%
+200,000
New +$3.51M

Similar funds

Iguana Healthcare Management's Q1 2016 Portfolio in Review

As of Q1 2016, Iguana Healthcare Management held 103 positions worth $273M, down 10% from $304M the previous quarter. Its ten largest holdings account for 42% of the portfolio.

Iguana Healthcare Management's Q1 2016 filing shows 39 new, 16 increased, 16 reduced and 28 closed positions. Its largest new stake was Zimmer Biomet: 87,550 shares worth $9.06M. The largest sale was Viatris, an estimated $12.2M.

By sector, the portfolio is most concentrated in Healthcare at 68% of assets, down from 78% a quarter earlier, followed by Industrials and Consumer Staples.

  • Iguana Healthcare Management's largest Q1 2016 buy was Zimmer Biomet: 87,550 shares worth $9.06M.
  • Iguana Healthcare Management added most to MEDIVATION, INC. in Q1 2016, an estimated $7.8M increase.
  • Iguana Healthcare Management's biggest Q1 2016 reduction was Amgen, cutting an estimated $9.66M.
  • Iguana Healthcare Management fully exited Viatris in Q1 2016, selling an estimated $12.2M.
  • Iguana Healthcare Management's ten largest holdings make up 42% of its $273M portfolio in Q1 2016.
  • Iguana Healthcare Management opened 39 new positions and closed 28 in Q1 2016.
  • Iguana Healthcare Management's portfolio value fell 10% quarter-over-quarter to $273M.

Based on Iguana Healthcare Management's 13F filing for Q1 2016, filed 17 May 2016.